{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:02:33Z","timestamp":1789945353462,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Celgene GmbH","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00520-019-04721-4","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T23:51:07Z","timestamp":1552348267000},"page":"4265-4271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology\/oncology group practices in Germany"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-7393","authenticated-orcid":false,"given":"Stefan","family":"Feiten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geothy","family":"Chakupurakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"Feustel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maasberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Otremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ehscheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Weide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"issue":"3","key":"4721_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.blre.2013.04.001","volume":"27","author":"A Palumbo","year":"2013","unstructured":"Palumbo A, Mina R (2013) Management of older adults with multiple myeloma. Blood Rev 27(3):133\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.blre.2013.04.001","journal-title":"Blood Rev"},{"issue":"7","key":"4721_CR2","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1038\/bcj.2016.53","volume":"6","author":"AM Rajan","year":"2016","unstructured":"Rajan AM, Kumar S (2016) New investigational drugs with single-agent activity in multiple myeloma. Blood Cancer J 6(7):e451. \n                    https:\/\/doi.org\/10.1038\/bcj.2016.53","journal-title":"Blood Cancer J"},{"issue":"11","key":"4721_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364(11):1046\u20131060. \n                    https:\/\/doi.org\/10.1056\/NEJMra1011442","journal-title":"N Engl J Med"},{"issue":"1","key":"4721_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2049-3258-72-37","volume":"72","author":"T Mathes","year":"2014","unstructured":"Mathes T, Jaschinski T, Pieper D (2014) Adherence influencing factors - a systematic review of systematic reviews. Arch Public Health 72(1):37. \n                    https:\/\/doi.org\/10.1186\/2049-3258-72-37","journal-title":"Arch Public Health"},{"issue":"11","key":"4721_CR5","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/sj.bjc.6604758","volume":"99","author":"C McCowan","year":"2008","unstructured":"McCowan C, Shearer J, Donnan PT, Dewar JA, Crilly M, Thompson AM, Fahey TP (2008) Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 99(11):1763\u20131768. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6604758","journal-title":"Br J Cancer"},{"issue":"14","key":"4721_CR6","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2010-10-309807","volume":"117","author":"AR Ibrahim","year":"2011","unstructured":"Ibrahim AR, Eliasson L, Apperley JF, Milojkovic D, Bua M, Szydlo R, Mahon FX, Kozlowski K, Paliompeis C, Foroni L, Khorashad JS, Bazeos A, Molimard M, Reid A, Rezvani K, Gerrard G, Goldman J, Marin D (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood 117(14):3733\u20133736. \n                    https:\/\/doi.org\/10.1182\/blood-2010-10-309807","journal-title":"Blood"},{"issue":"14","key":"4721_CR7","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1200\/jco.2009.26.3087","volume":"28","author":"D Marin","year":"2010","unstructured":"Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R, Desai R, Kozlowski K, Paliompeis C, Latham V, Foroni L, Molimard M, Reid A, Rezvani K, de Lavallade H, Guallar C, Goldman J, Khorashad JS (2010) Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol 28(14):2381\u20132388. \n                    https:\/\/doi.org\/10.1200\/jco.2009.26.3087","journal-title":"J Clin Oncol"},{"issue":"8","key":"4721_CR8","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00520-013-1831-6","volume":"21","author":"J Al-Barrak","year":"2013","unstructured":"Al-Barrak J, Cheung WY (2013) Adherence to imatinib therapy in gastrointestinal stromal tumors and chronic myeloid leukemia. Support Care Cancer 21(8):2351\u20132357. \n                    https:\/\/doi.org\/10.1007\/s00520-013-1831-6","journal-title":"Support Care Cancer"},{"issue":"3","key":"4721_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1634\/theoncologist.2015-0405","volume":"21","author":"JA Greer","year":"2016","unstructured":"Greer JA, Amoyal N, Nisotel L, Fishbein JN, MacDonald J, Stagl J, Lennes I, Temel JS, Safren SA, Pirl WF (2016) A systematic review of adherence to oral antineoplastic therapies. Oncologist 21(3):354\u2013376. \n                    https:\/\/doi.org\/10.1634\/theoncologist.2015-0405","journal-title":"Oncologist"},{"issue":"1","key":"4721_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3322\/caac.20004","volume":"59","author":"K Ruddy","year":"2009","unstructured":"Ruddy K, Mayer E, Partridge A (2009) Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 59(1):56\u201366. \n                    https:\/\/doi.org\/10.3322\/caac.20004","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4721_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK (2008) Medication compliance and persistence: terminology and definitions. Value Health 11(1):44\u201347. \n                    https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00213.x","journal-title":"Value Health"},{"issue":"1","key":"4721_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JOP.2010.000076","volume":"7","author":"J Hohneker","year":"2011","unstructured":"Hohneker J, Shah-Mehta S, Brandt PS (2011) Perspectives on adherence and persistence with oral medications for cancer treatment. J Oncol Pract 7(1):65\u201367. \n                    https:\/\/doi.org\/10.1200\/JOP.2010.000076","journal-title":"J Oncol Pract"},{"issue":"2","key":"4721_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2143\/ACB.66.2.2062525","volume":"66","author":"V Foulon","year":"2011","unstructured":"Foulon V, Schoffski P, Wolter P (2011) Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 66(2):85\u201396. \n                    https:\/\/doi.org\/10.2143\/ACB.66.2.2062525","journal-title":"Acta Clin Belg"},{"issue":"5","key":"4721_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/01.mlr.0000207817.32496.cb","volume":"44","author":"R Grymonpre","year":"2006","unstructured":"Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS (2006) Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 44(5):471\u2013477. \n                    https:\/\/doi.org\/10.1097\/01.mlr.0000207817.32496.cb","journal-title":"Med Care"},{"issue":"5","key":"4721_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","volume":"26","author":"E Vermeire","year":"2001","unstructured":"Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26(5):331\u2013342","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"4721_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ijnurstu.2008.02.009","volume":"45","author":"M Banning","year":"2008","unstructured":"Banning M (2008) Older people and adherence with medication: a review of the literature. Int J Nurs Stud 45(10):1550\u20131561. \n                    https:\/\/doi.org\/10.1016\/j.ijnurstu.2008.02.009","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"4721_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2354.2011.01295.x","volume":"21","author":"M Banning","year":"2012","unstructured":"Banning M (2012) Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care 21(1):10\u201319. \n                    https:\/\/doi.org\/10.1111\/j.1365-2354.2011.01295.x","journal-title":"Eur J Cancer Care"},{"issue":"6","key":"4721_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1200\/jco.1993.11.6.1189","volume":"11","author":"DM Waterhouse","year":"1993","unstructured":"Waterhouse DM, Calzone KA, Mele C, Brenner DE (1993) Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 11(6):1189\u20131197. \n                    https:\/\/doi.org\/10.1200\/jco.1993.11.6.1189","journal-title":"J Clin Oncol"},{"issue":"12","key":"4721_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.12968\/bjcn.2006.11.12.22424","volume":"11","author":"P Escalada","year":"2006","unstructured":"Escalada P, Griffiths P (2006) Do people with cancer comply with oral chemotherapy treatments? Br J Community Nurs 11(12):532\u2013536. \n                    https:\/\/doi.org\/10.12968\/bjcn.2006.11.12.22424","journal-title":"Br J Community Nurs"},{"key":"4721_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2017.05.002","volume":"57","author":"AR Mislang","year":"2017","unstructured":"Mislang AR, Wildes TM, Kanesvaran R, Baldini C, Holmes HM, Nightingale G, Coolbrandt A, Biganzoli L (2017) Adherence to oral cancer therapy in older adults: the International Society of Geriatric Oncology (SIOG) taskforce recommendations. Cancer Treat Rev 57:58\u201366. \n                    https:\/\/doi.org\/10.1016\/j.ctrv.2017.05.002","journal-title":"Cancer Treat Rev"},{"issue":"4 Suppl 2","key":"4721_CR21","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.soncn.2007.10.004","volume":"23","author":"FM Palmieri","year":"2007","unstructured":"Palmieri FM, Barton DL (2007) Challenges of oral medications in patients with advanced breast cancer. Semin Oncol Nurs 23(4 Suppl 2):S17\u2013S22. \n                    https:\/\/doi.org\/10.1016\/j.soncn.2007.10.004","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"4721_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pds.819","volume":"13","author":"PS Wang","year":"2004","unstructured":"Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J (2004) How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 13(1):11\u201319. \n                    https:\/\/doi.org\/10.1002\/pds.819","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"4721_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1590\/S0004-28032014000300004","volume":"51","author":"AG Figueiredo Junior","year":"2014","unstructured":"Figueiredo Junior AG, Forones NM (2014) Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer. Arq Gastroenterol 51(3):186\u2013191","journal-title":"Arq Gastroenterol"},{"issue":"5","key":"4721_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487\u2013497. \n                    https:\/\/doi.org\/10.1056\/NEJMra050100","journal-title":"N Engl J Med"},{"issue":"21","key":"4721_CR25","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.7314\/APJCP.2014.15.21.9225","volume":"15","author":"AK Zahrina","year":"2014","unstructured":"Zahrina AK, Norsa'adah B, Hassan NB, Norazwany Y, Norhayati I, Roslan MH, Wan Nazuha WR (2014) Adherence to capecitabine treatment and contributing factors among cancer patients in Malaysia. Asian Pac J Cancer Prev 15(21):9225\u20139232","journal-title":"Asian Pac J Cancer Prev"},{"key":"4721_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s40064-016-1851-z","volume":"5","author":"S Feiten","year":"2016","unstructured":"Feiten S, Weide R, Friesenhahn V, Heymanns J, Kleboth K, Koppler H, van Roye C, Thomalla J (2016) Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice. SpringerPlus 5:270. \n                    https:\/\/doi.org\/10.1186\/s40064-016-1851-z","journal-title":"SpringerPlus"},{"issue":"8476","key":"4721_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307\u2013310","journal-title":"Lancet"},{"issue":"30","key":"4721_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3238\/arztebl.2011.0515","volume":"108","author":"R Kwiecien","year":"2011","unstructured":"Kwiecien R, Kopp-Schneider A, Blettner M (2011) Concordance analysis: part 16 of a series on evaluation of scientific publications. Dtsch Arztebl Int 108(30):515\u2013521. \n                    https:\/\/doi.org\/10.3238\/arztebl.2011.0515","journal-title":"Dtsch Arztebl Int"},{"key":"4721_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00761-017-0237-3","volume":"23","author":"W Baumann","year":"2017","unstructured":"Baumann W, Welslau M (2017) Patientenadh\u00e4renz in der oralen medizinischen Onkologie. Onkologe 23:645\u2013650. \n                    https:\/\/doi.org\/10.1007\/s00761-017-0237-3","journal-title":"Onkologe"},{"issue":"3","key":"4721_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/annonc\/mdn646","volume":"20","author":"V Ziller","year":"2009","unstructured":"Ziller V, Kalder M, Albert US, Holzhauer W, Ziller M, Wagner U, Hadji P (2009) Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Annals of oncology: official journal of the European society for. Med Oncol 20(3):431\u2013436. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdn646","journal-title":"Med Oncol"},{"issue":"1\u20132","key":"4721_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000328317","volume":"80","author":"R Winterhalder","year":"2011","unstructured":"Winterhalder R, Hoesli P, Delmore G, Pederiva S, Bressoud A, Hermann F, von Moos R (2011) Self-reported compliance with capecitabine: findings from a prospective cohort analysis. Oncology 80(1\u20132):29\u201333. \n                    https:\/\/doi.org\/10.1159\/000328317","journal-title":"Oncology"},{"issue":"1","key":"4721_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3747\/co.22.2219","volume":"22","author":"AD Smith","year":"2015","unstructured":"Smith AD, Olson C, Lyons B, Tran D, Blackburn DF (2015) Adherence to abiraterone among the first 86 recipients after release in Saskatchewan. Curr Oncol 22(1):64\u201367. \n                    https:\/\/doi.org\/10.3747\/co.22.2219","journal-title":"Curr Oncol"},{"issue":"8","key":"4721_CR33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00432-015-1935-0","volume":"141","author":"L Timmers","year":"2015","unstructured":"Timmers L, Boons CC, Moes-Ten Hove J, Smit EF, van de Ven PM, Aerts JG, Swart EL, Boven E, Hugtenburg JG (2015) Adherence, exposure and patients\u2019 experiences with the use of erlotinib in non-small cell lung cancer. J Cancer Res Clin Oncol 141(8):1481\u20131491. \n                    https:\/\/doi.org\/10.1007\/s00432-015-1935-0","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"4721_CR34","doi-asserted-by":"publisher","first-page":"e12413","DOI":"10.1111\/ecc.12413","volume":"26","author":"A. Arber","year":"2015","unstructured":"Arber A, Odelius A, Williams P, Lemanska A, Faithfull S (2017) Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study. Eur J Cancer Care 26(2). \n                    https:\/\/doi.org\/10.1111\/ecc.12413","journal-title":"European Journal of Cancer Care"},{"issue":"2","key":"4721_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/0284186x.2013.844353","volume":"53","author":"L Timmers","year":"2014","unstructured":"Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG (2014) Adherence and patients\u2019 experiences with the use of oral anticancer agents. Acta Oncol (Stockh) 53(2):259\u2013267. \n                    https:\/\/doi.org\/10.3109\/0284186x.2013.844353","journal-title":"Acta Oncol (Stockh)"},{"issue":"5","key":"4721_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jgo.2016.07.010","volume":"7","author":"M Sharma","year":"2016","unstructured":"Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM (2016) Polypharmacy and potentially inappropriate medication use in geriatric oncology. J Geriatr Oncol 7(5):346\u2013353. \n                    https:\/\/doi.org\/10.1016\/j.jgo.2016.07.010","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"4721_CR37","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00520-010-0927-5","volume":"19","author":"S Simons","year":"2011","unstructured":"Simons S, Ringsdorf S, Braun M, Mey UJ, Schwindt PF, Ko YD, Schmidt-Wolf I, Kuhn W, Jaehde U (2011) Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 19(7):1009\u20131018. \n                    https:\/\/doi.org\/10.1007\/s00520-010-0927-5","journal-title":"Support Care Cancer"},{"issue":"3","key":"4721_CR38","first-page":"163","volume":"5","author":"SM Schneider","year":"2014","unstructured":"Schneider SM, Adams DB, Gosselin T (2014) A tailored nurse coaching intervention for oral chemotherapy adherence. J Adv Pract Oncol 5(3):163\u2013172","journal-title":"J Adv Pract Oncol"},{"issue":"21","key":"4721_CR39","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2217\/fon-2017-0727","volume":"14","author":"Ajai Chari","year":"2018","unstructured":"Chari A, Bhor M, Eldjerou L, Gilligan AM, Urniasz A, Globe D, Stetsovsky D, Varker H, Davis B, Bonafede M, Talcott J (2018) Treatment patterns and medication adherence among patients diagnosed with multiple myeloma and treated with panobinostat. Future Oncol. \n                    https:\/\/doi.org\/10.2217\/fon-2017-0727","journal-title":"Future Oncology"},{"key":"4721_CR40","first-page":"A136","volume":"24","author":"ASB Cransac","year":"2017","unstructured":"Cransac ASB, Marty-Quinternet S, Pernot C, Caillot D, Boulin M (2017) DI-053 adherence to immunomodulatory drugs in patients with multiple myeloma. Eur J Hosp Pharm 24:A136\u2013A137","journal-title":"Eur J Hosp Pharm"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-04721-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04721-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:13:41Z","timestamp":1583799221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-04721-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4721"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-04721-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"20 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}